Enanta Pharmaceuticals Inc

CHARLES SCHWAB INVESTMENT MANAGEMENT INC ENTA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

218,636

Value ($000)

3,448

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	3,448	0.0%	218,636	12/31/2025
2025 Q3	11/10/2025	1,994	0.0%	166,547	9/30/2025
2025 Q2	8/12/2025	1,245	0.0%	164,647	6/30/2025
2025 Q1	9/15/2025	882	0.0%	159,801	3/31/2025
2024 Q4	2/6/2025	890	0.0%	154,827	12/31/2024
2024 Q3	11/12/2024	1,682	0.0%	162,398	9/30/2024
2024 Q2	8/12/2024	2,128	0.0%	164,047	6/30/2024
2024 Q1	5/9/2024	2,811	0.0%	161,000	3/31/2024
2023 Q4	2/6/2024	1,386	0.0%	147,331	12/31/2023
2023 Q3	11/8/2023	1,749	0.0%	156,622	9/30/2023
2023 Q2	8/10/2023	3,245	0.0%	151,657	6/30/2023
2023 Q1	5/12/2023	6,008	0.0%	148,558	3/31/2023
2022 Q4	2/13/2023	6,787	0.0%	145,890	12/31/2022
2022 Q3	11/14/2022	7,372	0.0%	142,107	9/30/2022
2022 Q2	8/15/2022	6,346	0.0%	134,231	6/30/2022
2022 Q1	5/13/2022	9,690	0.0%	136,126	3/31/2022
2021 Q4	2/11/2022	9,667	0.0%	129,263	12/31/2021
2021 Q3	11/16/2021	7,258	0.0%	127,746	9/30/2021
2021 Q2	8/16/2021	5,578	0.0%	126,731	6/30/2021
2021 Q1	5/17/2021	6,148	0.0%	124,640	3/31/2021
2020 Q4	2/16/2021	5,083	0.0%	120,732	12/31/2020
2020 Q3	11/13/2020	5,399	0.0%	117,930	9/30/2020
2020 Q2	8/20/2020	5,767	0.0%	114,856	6/30/2020
2020 Q1	5/15/2020	5,531	0.0%	107,540	3/31/2020
2019 Q4	2/7/2020	6,736	0.0%	109,019	12/31/2019
2014 Q2	7/30/2014	761	0.0%	17,654	6/30/2014
2014 Q1	4/29/2014	313	0.0%	7,802	3/31/2014
2013 Q4	2/14/2014	208	0.0%	7,622	12/31/2013